Dose Modulation Strategies in Psoriatic Patients: Real‐Life Pilot Comparison Between Risankizumab and Guselkumab up to 12 Months After Dose Spacing. - Mastorino, Luca; Dapavo, Paolo; Ortoncelli, Michela; Bongiovanni, Eleonora; Liao, Yingying; Leo, Francesco; Quaglino, Pietro; Ribero, Simone (Experimental Dermatology, 2025)